vs
Side-by-side financial comparison of KeyCorp (KEY) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
KeyCorp is the larger business by last-quarter revenue ($2.0B vs $1.5B, roughly 1.3× BeOne Medicines Ltd.). KeyCorp runs the higher net margin — 25.4% vs 4.4%, a 21.0% gap on every dollar of revenue. On growth, KeyCorp posted the faster year-over-year revenue change (131.8% vs 32.8%). KeyCorp produced more free cash flow last quarter ($2.1B vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 14.4%).
Key is a Japanese visual novel studio known for making dramatic and plot-oriented titles. It was formed on July 21, 1998, as a brand under the publisher Visual Arts, and is located in Kita, Osaka.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
KEY vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.0B | $1.5B |
| Net Profit | $510.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 32.3% | 12.4% |
| Net Margin | 25.4% | 4.4% |
| Revenue YoY | 131.8% | 32.8% |
| Net Profit YoY | 309.0% | 143.8% |
| EPS (diluted) | $0.43 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.0B | $1.5B | ||
| Q3 25 | $1.9B | $1.4B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.8B | $1.1B | ||
| Q4 24 | $865.0M | $1.1B | ||
| Q3 24 | $695.0M | $1.0B | ||
| Q2 24 | $1.5B | $929.2M | ||
| Q1 24 | $1.5B | $751.7M |
| Q4 25 | $510.0M | $66.5M | ||
| Q3 25 | $489.0M | $124.8M | ||
| Q2 25 | $425.0M | $94.3M | ||
| Q1 25 | $405.0M | $1.3M | ||
| Q4 24 | $-244.0M | $-151.9M | ||
| Q3 24 | $-410.0M | $-121.3M | ||
| Q2 24 | $274.0M | $-120.4M | ||
| Q1 24 | $219.0M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 32.3% | 12.4% | ||
| Q3 25 | 31.8% | 11.5% | ||
| Q2 25 | 29.3% | 6.7% | ||
| Q1 25 | 29.0% | 1.0% | ||
| Q4 24 | -92.6% | -7.0% | ||
| Q3 24 | -72.8% | -12.0% | ||
| Q2 24 | 22.0% | -11.5% | ||
| Q1 24 | 18.1% | -34.8% |
| Q4 25 | 25.4% | 4.4% | ||
| Q3 25 | 25.8% | 8.8% | ||
| Q2 25 | 23.1% | 7.2% | ||
| Q1 25 | 22.8% | 0.1% | ||
| Q4 24 | -54.7% | -13.5% | ||
| Q3 24 | -59.0% | -12.1% | ||
| Q2 24 | 18.0% | -13.0% | ||
| Q1 24 | 14.3% | -33.4% |
| Q4 25 | $0.43 | $0.05 | ||
| Q3 25 | $0.41 | $0.08 | ||
| Q2 25 | $0.35 | $0.06 | ||
| Q1 25 | $0.33 | $0.00 | ||
| Q4 24 | $-0.30 | $-0.10 | ||
| Q3 24 | $-0.47 | $-0.09 | ||
| Q2 24 | $0.25 | $-0.09 | ||
| Q1 24 | $0.20 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.2B | $4.5B |
| Total DebtLower is stronger | $9.9B | $836.4M |
| Stockholders' EquityBook value | $20.4B | $4.4B |
| Total Assets | $184.4B | $8.2B |
| Debt / EquityLower = less leverage | 0.49× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.2B | $4.5B | ||
| Q3 25 | $13.3B | $4.0B | ||
| Q2 25 | $11.6B | $2.8B | ||
| Q1 25 | $15.3B | $2.5B | ||
| Q4 24 | $17.5B | $2.6B | ||
| Q3 24 | $22.8B | $2.7B | ||
| Q2 24 | $15.5B | $2.6B | ||
| Q1 24 | $13.2B | $2.8B |
| Q4 25 | $9.9B | $836.4M | ||
| Q3 25 | $10.9B | — | ||
| Q2 25 | $12.1B | — | ||
| Q1 25 | $12.4B | — | ||
| Q4 24 | $12.1B | — | ||
| Q3 24 | $15.7B | — | ||
| Q2 24 | $16.9B | — | ||
| Q1 24 | $20.8B | — |
| Q4 25 | $20.4B | $4.4B | ||
| Q3 25 | $20.1B | $4.1B | ||
| Q2 25 | $19.5B | $3.8B | ||
| Q1 25 | $19.0B | $3.5B | ||
| Q4 24 | $18.2B | $3.3B | ||
| Q3 24 | $16.9B | $3.4B | ||
| Q2 24 | $14.8B | $3.4B | ||
| Q1 24 | $14.5B | $3.4B |
| Q4 25 | $184.4B | $8.2B | ||
| Q3 25 | $187.4B | $7.6B | ||
| Q2 25 | $185.5B | $6.3B | ||
| Q1 25 | $188.7B | $5.8B | ||
| Q4 24 | $187.2B | $5.9B | ||
| Q3 24 | $189.8B | $5.8B | ||
| Q2 24 | $187.4B | $5.7B | ||
| Q1 24 | $187.5B | $5.7B |
| Q4 25 | 0.49× | 0.19× | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | 0.67× | — | ||
| Q3 24 | 0.93× | — | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 1.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.2B | $417.3M |
| Free Cash FlowOCF − Capex | $2.1B | $379.8M |
| FCF MarginFCF / Revenue | 104.8% | 25.4% |
| Capex IntensityCapex / Revenue | 5.3% | 2.5% |
| Cash ConversionOCF / Net Profit | 4.33× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $3.5B | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.2B | $417.3M | ||
| Q3 25 | $396.0M | $402.6M | ||
| Q2 25 | $1.2B | $263.6M | ||
| Q1 25 | $-140.0M | $44.1M | ||
| Q4 24 | $664.0M | $75.2M | ||
| Q3 24 | $-1.2B | $188.4M | ||
| Q2 24 | $-217.0M | $-95.6M | ||
| Q1 24 | $359.0M | $-308.6M |
| Q4 25 | $2.1B | $379.8M | ||
| Q3 25 | $367.0M | $354.5M | ||
| Q2 25 | $1.2B | $219.8M | ||
| Q1 25 | $-150.0M | $-12.3M | ||
| Q4 24 | $599.0M | $-17.3M | ||
| Q3 24 | $-1.2B | $54.7M | ||
| Q2 24 | $-230.0M | $-205.5M | ||
| Q1 24 | $347.0M | $-465.1M |
| Q4 25 | 104.8% | 25.4% | ||
| Q3 25 | 19.4% | 25.1% | ||
| Q2 25 | 65.8% | 16.7% | ||
| Q1 25 | -8.5% | -1.1% | ||
| Q4 24 | 69.2% | -1.5% | ||
| Q3 24 | -175.8% | 5.5% | ||
| Q2 24 | -15.1% | -22.1% | ||
| Q1 24 | 22.6% | -61.9% |
| Q4 25 | 5.3% | 2.5% | ||
| Q3 25 | 1.5% | 3.4% | ||
| Q2 25 | 1.3% | 3.3% | ||
| Q1 25 | 0.6% | 5.0% | ||
| Q4 24 | 7.5% | 8.2% | ||
| Q3 24 | 2.4% | 13.3% | ||
| Q2 24 | 0.9% | 11.8% | ||
| Q1 24 | 0.8% | 20.8% |
| Q4 25 | 4.33× | 6.28× | ||
| Q3 25 | 0.81× | 3.22× | ||
| Q2 25 | 2.90× | 2.79× | ||
| Q1 25 | -0.35× | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.79× | — | ||
| Q1 24 | 1.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
